Peter Miller joined the Board of Directors of OptiNose AS in 2008, at which time he first became familiar with the company’s unique approach to nasal drug delivery and convinced of the potential for using it to create clinically important new products.  In 2010, in partnership with Ramy Mahmoud, Peter led the start-up of OptiNose Inc in collaboration with Avista Capital Partners, acquiring OptiNose AS and accepting the role of CEO.  He is a member of the Board of Directors of OptiNose Inc. Mr. Miller was previously the Co-Founder, CEO and President of Take Care Health Systems, a company that, through a revolutionary idea to operate medical clinics inside Walgreen’s retail pharmacies, is disrupting the U.S. Healthcare system. Miller served as a Vice President in the Walgreen’s Health and Wellness Division and remained CEO for Take Care Health Systems for three years after its sale to Walgreen’s, while growing the clinic operation to more than 400 clinics nationwide. Earlier, Mr. Miller spent more than 15 years at Johnson & Johnson, serving in a variety of marketing and general management roles that included Worldwide President of Johnson & Johnson – Merck Consumer Pharmaceuticals, and President of Janssen Pharmaceutica, a $4 billion dollar pharmaceutical company. While at J&J, he played an integral role in building brands such as Tylenol, Motrin, Imodium, Pepcid, Duragesic, Risperdal and Aciphex. Mr. Miller earned an economics degree from Trinity College and an MBA from the Kellogg School of Management at Northwestern University.  

nasal drug delivery , Pharmaceuticals,medical clinics